New project to help tackle Type 1 Diabetes

Image: Pixabay - The Australian National University (ANU) has announced a new research project with Janssen Research & Development, LLC, aimed at improving health outcomes in Type 1 Diabetes (T1D). The collaboration was facilitated by Johnson & Johnson Innovation. The project will focus on the development of new methods for measuring and monitoring disease activity. Type 1 Diabetes is an autoimmune disease that attacks the body's ability to process sugar by destroying insulin-producing beta cells in the pancreas. Researchers from ANU will test new methods of monitoring this damage, as part of the wider effort to develop preventive measures and therapies. Together with Janssen scientists, researchers from ANU aim to identify individuals at risk of T1D and track markers and influences in childhood to identify the opportunity and means to intervene early in the course of disease. "The goal of this initiative is to discover avenues for interception that will enable a brighter future for individuals at risk of developing symptomatic T1D," said Charmaine Simeonovic, Associate Professor and Chief Investigator.